Brain training and the end of the Prozac generation
Mar27
on March 27, 2015
at 5:09 pm
Robert J. Szczerba is the CEO of X Tech Ventures, an innovative company focused on solving some of today’s most challenging problems through the integration of technologies from multiple, diverse domains. This post originally appeared on Forbes. More than 20 percent of Americans regularly consume prescribed drugs related to mental health issues, earning contemporary America the nickname, “the Prozac Generation.” However, developing safe, targeted, and effective drugs for mental illnesses has increasingly become a struggle for the pharmaceutical industry. As a result, there’s been a gradual withdrawal of research dollars from this area, despite the fact that globally, the mental health…
This story continues at The Next Web